Recbio Technology's Chair Steps Down; Successor Named

MT Newswires Live2025-12-23

Jiangsu Recbio Technology's (HKG:2179) Chairman Liu Yong resigned to dedicate more time to other commitments, a Tuesday Hong Kong bourse filing said.

Liu will continue to serve as the vaccine maker's general manager.

The firm, on Tuesday, named Xu Haoyu as its new chairman.

Xu has been the chairman and president of Yangtze River Pharmaceutical (Group) since July 2021.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment